A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes

December 1, 2016 updated by: Fernando Civeira, Instituto Aragones de Ciencias de la Salud
The objective of the study is to assess the effect of low-calorie diets with normal (18%) vs. high (35%) protein (mainly coming from animal source) composition on body weight and carbohydrates metabolism in overweight and obese subjects with pre-diabetes or diabetes. A dietary intervention is carried out during 6 months in 100 subjects who are individually randomized to an energy-restricted diet with two types of macronutrients composition: 1) 35% protein, 30% fat and 35% carbohydrates and 2) 18% protein, 30% fat and 52% carbohydrates. Around 80% of total protein in diet comes from animal source (of whom around 40% from lean red meat). Subjects are provided with weekly menus and different recipes to use them as part of the diet. Monitoring visits with the nutritionist will be performed every 15 days. At the beginning of the study, after 3 and 6 months, the following parameters are determined: anthropometric (weight, waist circumference, body mass index and body composition), blood pressure, dietary (72-hours dietary registry) and exercise and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoproteins A1 and B, iron, transferring, ferritin, uric acid, glucose, HbA1c, insulin, adiponectin and resistin). Urine samples are also collected to assess microalbuminuria and ureic nitrogen.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Fernando Civeira, MD, PhD
  • Phone Number: 2884 +34 976765500
  • Email: civeira@unizar.es

Study Contact Backup

Study Locations

      • Zaragoza, Spain, 50009
        • Recruiting
        • Fernando Civeira
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 18-70 years old.
  • Body mass index between 27.5 - 40.
  • Steady weight (± 4 kg) in the last 2 months.
  • Glycated hemoglobin between 6 - 7%.

Exclusion Criteria:

  • Anti-diabetic drugs (oral or subcutaneous) in the last 2 months.
  • Lipid-lowering drugs in the last 2 months.
  • Gouty arthritis in the last 2 years or uric acid > 735 mg/dl.
  • Presence of uncontrolled endocrinological pathology (including hypothyroidism).
  • Hepatic chronic disease (glomerular filtration rate < 45 ml/min).
  • Renal, inflammatory or tumoral diseases.
  • Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy.
  • Intake of functional foods with plant sterols in the past 6 weeks.
  • High alcohol intake (> 30 g per day).
  • Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study.
  • Pregnancy or intention of pregnancy during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 18%-Protein diet
Energy-restricted diet wit the following composition: 18% protein, 30% fat and 52% carbohydrates
Active Comparator: 35%-Protein diet
Energy-restricted diet wit the following composition: 35% protein, 30% fat and 35% carbohydrates

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in glucose.
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.
Change in glycated hemoglobin.
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.
Change in insulin resistance (HOMA index).
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in body weight.
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.
Change in body composition.
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.
Change in waist circumference.
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.
Change in lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, non HDL cholesterol, triglycerides and apolipoproteins).
Time Frame: After 3 and 6 months of intervention.
After 3 and 6 months of intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fernando Civeira, MD, PhD, Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis; Hospital U. Miguel Servet; IIS Aragón

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Anticipated)

June 1, 2017

Study Completion (Anticipated)

June 1, 2017

Study Registration Dates

First Submitted

September 22, 2015

First Submitted That Met QC Criteria

September 23, 2015

First Posted (Estimate)

September 24, 2015

Study Record Updates

Last Update Posted (Estimate)

December 2, 2016

Last Update Submitted That Met QC Criteria

December 1, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Weight loss interventional study with a low-calorie 18%-protein diet

3
Subscribe